An official website of the United States government
CIBMTR Research Database
Trial Status: active
The primary purpose of the Research Database is to have a comprehensive source of
observational data that can be used to study HSC transplantation and cellular therapies.
A secondary purpose of the Research Database is to have a comprehensive source of data to
study marrow toxic injuries.
Objectives:
To learn more about what makes stem cell transplants and cellular therapies work well
such as:
- Determine how well recipients recover from their transplants or cellular therapy;
- Determine how recovery after a transplant or cellular therapy can be improved;
- Determine how a donor's or recipient's genetics impact recipient recovery after a
transplant or cellular therapy;
- Determine how access to transplant or cellular therapy for different groups of
patients can be improved;
- Determine how well donors recover from the collection procedures.
Inclusion Criteria
Eligibility to Participate in the Research Database
Recipient Eligibility Criteria:
- Any recipient of an unrelated or related donor or autologous HSC transplant in a
CIBMTR center is eligible to participate in the Research Database. This includes
adults with and without decision making capacity, and children.
Individual with Marrow Toxic Injury Eligibility Criteria:
- Any individual who is treated for a marrow toxic injury at a center participating in
the NMDP's Radiation Injury Transplant Network (RITN) is eligible to participate in
the Research Database. This includes adults with and without decision making
capacity, and children. Eligible individuals may have received supportive care only,
growth factor support, HSC transplant or other appropriate medical treatment for
marrow toxic injury. Treatments applied are at the discretion of the care facility,
and are not determined by the NMDP or CIBMTR.
Unrelated Donor Eligibility Criteria:
- All donors registered on the NMDP Registry who have been requested to donate a
product for a recipient are eligible to participate in the Research Database.
- All maternal cord blood donors are enrolled in the NMDP Cord Blood Bank
Investigational New Drug (IND) protocol, and sign an informed consent document
specific to that protocol. Data collected as part of the Cord Blood Bank protocol
are included in the Research Database.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT01166009.
Locations matching your search criteria
United States
Arizona
Tucson
Banner University Medical Center - Tucson
Status: Active
Name Not Available
California
Duarte
City of Hope Comprehensive Cancer Center
Status: Active
Name Not Available
Los Angeles
Children's Hospital Los Angeles
Status: Active
Name Not Available
Florida
Miami
University of Miami Miller School of Medicine-Sylvester Cancer Center
